深表现型患者与柠檬素缺乏症在新加坡-单中心经验。

IF 3.5 2区 生物学 Q2 ENDOCRINOLOGY & METABOLISM
Molecular genetics and metabolism Pub Date : 2025-09-01 Epub Date: 2025-07-29 DOI:10.1016/j.ymgme.2025.109215
Mildrid Yeo, Jeannette Lay Kuan Goh, Ai Ling Koh, Nikki Fong, Ee Shien Tan, Saumya Jamuar, Chew Yin Jasmine Goh, Eunice Lim, Sherry Poh, Soon Chuan James Lim, Sylvia Kam, Breana Cham, Jiin Ying Lim, Kong Boo Phua, Fang Kuan Chiou, Veena Logarajah, Christopher Wen Wei Ho, Lay Queen Ng, Sarah Ailyne Wong, Lynette Goh, Christine Ong, Grace Quek, Chengsi Ong, Kar Yin Phuah, Teck Wah Ting
{"title":"深表现型患者与柠檬素缺乏症在新加坡-单中心经验。","authors":"Mildrid Yeo, Jeannette Lay Kuan Goh, Ai Ling Koh, Nikki Fong, Ee Shien Tan, Saumya Jamuar, Chew Yin Jasmine Goh, Eunice Lim, Sherry Poh, Soon Chuan James Lim, Sylvia Kam, Breana Cham, Jiin Ying Lim, Kong Boo Phua, Fang Kuan Chiou, Veena Logarajah, Christopher Wen Wei Ho, Lay Queen Ng, Sarah Ailyne Wong, Lynette Goh, Christine Ong, Grace Quek, Chengsi Ong, Kar Yin Phuah, Teck Wah Ting","doi":"10.1016/j.ymgme.2025.109215","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Citrin deficiency (CD) is a pan-ethnic autosomal recessive inborn error of metabolism due to-pathogenic variants in the SLC25A13 gene which results in disruptions of multiple metabolic pathways including glycolysis, gluconeogenesis, lipogenesis, the urea cycle, and tricarboxylic cycle.</p><p><strong>Methods: </strong>A retrospective observational study of CD patients managed according to standard clinical practice at a single centre in Singapore (KK Women's and Children's Hospital, KKH) was undertaken from August 2016-August 2024. We present the largest cohort of patients reported in Southeast Asia focusing on clinical, biochemical and imaging findings at diagnosis, and long-term outcomes/management (including drug therapy, food preferences/adherence, hospital admissions, growth, neurodevelopmental, biochemical, and imaging outcomes). We also explore the utility of newborn screening (NBS) as a means for early detection of CD.</p><p><strong>Results: </strong>Eighteen CD patients (9 males; 2 sibling pairs) majority of Chinese ethnicity (n = 16) with a median duration of follow up 5 years 5 months, participated in this study. Median age at first presentation and at diagnosis was 50 days and 82 days, respectively. Fourteen patients presented with neonatal intrahepatic cholestasis caused by CD (NICCD), 2 asymptomatic from sibling screens, and two from abnormalities on NBS (one presenting with unconjugated hyperbilirubinaemia and the other with cholestasis and liver failure). Two patients had liver failure (one from NICCD group and another from NBS group). None required liver transplantation. All symptomatic patients had raised citrulline and threonine-serine ratios at presentation. None of the patients was prescribed any regular concomitant medications except for MCT oil. No genotype phenotype correlation was observed. At final assessment, all patients showed normalisation of liver parameter, galactose and plasma amino acids. Abnormalities in lipid profile in 9 patients (age 5-16 years) showed borderline high total cholesterol (median 5.4 mmol/L) and LDL (median 3.0 mmol/L) which was on the higher end of the normal range. Sixty-six percent of patients liver imaging findings were normal or showed stable changes. Food preferences (assessed in ≥1-year olds) did not reflect a clear bias towards high protein/fat diet. Adherence appeared to improve with a more prescriptive approach, it waned with age (more so in dietary aspects versus the use of MCT oil). Hospital admissions were few (median 1/patient) and unrelated to CD. Overall improvements were seen in weight, height and BMI for age z-scores, showing median weight/height/BMI for age z-scores to be -0.72, -0.83, 0.08, respectively. None had neurodevelopmental concerns.</p><p><strong>Conclusion: </strong>CD remains challenging to diagnose biochemically at all ages. Current NBS strategies require further refining to increase pick up rates of CD. Cascade screening utilising genetic testing is recommended due to the presence of phenotypic heterogeneity among patients with the same genotype. However, in the absence of available genetic testing, CD should be considered in all children presenting with prolonged conjugated hyperbilirubinaemia in the presence of elevated ALP, total galactose, with/without transaminitis and typical PAA profile. With our standard treatment for CD, we observed: (i) normalisation of biochemical parameters, (ii) normalisation/stabilisation of liver imaging findings, (iii) improvements in weight/height/BMI for age scores. Adoption of a prescriptive approach appeared to encourage treatment adherence.</p><p><strong>Synopsis: </strong>This retrospective study examines 18 patients with citrin deficiency at KK Women's and Children's Hospital in Singapore, the largest cohort reported in Southeast Asia. The study assesses clinical, biochemical, imaging findings, and outcome measures. Results showed improvements in growth, biochemical normalisation, and stable liver imaging with standard treatment (dietary adjustments and MCT oil). While NBS detected some cases, there remains a need for better screening strategies. This study also demonstrated a lack of genotype-phenotype correlation, suggesting that cascade screening utilising genetic testing are crucial for early diagnosis.</p>","PeriodicalId":18937,"journal":{"name":"Molecular genetics and metabolism","volume":"146 1-2","pages":"109215"},"PeriodicalIF":3.5000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Deep phenotyping of patients with citrin deficiency in Singapore- single centre experience.\",\"authors\":\"Mildrid Yeo, Jeannette Lay Kuan Goh, Ai Ling Koh, Nikki Fong, Ee Shien Tan, Saumya Jamuar, Chew Yin Jasmine Goh, Eunice Lim, Sherry Poh, Soon Chuan James Lim, Sylvia Kam, Breana Cham, Jiin Ying Lim, Kong Boo Phua, Fang Kuan Chiou, Veena Logarajah, Christopher Wen Wei Ho, Lay Queen Ng, Sarah Ailyne Wong, Lynette Goh, Christine Ong, Grace Quek, Chengsi Ong, Kar Yin Phuah, Teck Wah Ting\",\"doi\":\"10.1016/j.ymgme.2025.109215\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Citrin deficiency (CD) is a pan-ethnic autosomal recessive inborn error of metabolism due to-pathogenic variants in the SLC25A13 gene which results in disruptions of multiple metabolic pathways including glycolysis, gluconeogenesis, lipogenesis, the urea cycle, and tricarboxylic cycle.</p><p><strong>Methods: </strong>A retrospective observational study of CD patients managed according to standard clinical practice at a single centre in Singapore (KK Women's and Children's Hospital, KKH) was undertaken from August 2016-August 2024. We present the largest cohort of patients reported in Southeast Asia focusing on clinical, biochemical and imaging findings at diagnosis, and long-term outcomes/management (including drug therapy, food preferences/adherence, hospital admissions, growth, neurodevelopmental, biochemical, and imaging outcomes). We also explore the utility of newborn screening (NBS) as a means for early detection of CD.</p><p><strong>Results: </strong>Eighteen CD patients (9 males; 2 sibling pairs) majority of Chinese ethnicity (n = 16) with a median duration of follow up 5 years 5 months, participated in this study. Median age at first presentation and at diagnosis was 50 days and 82 days, respectively. Fourteen patients presented with neonatal intrahepatic cholestasis caused by CD (NICCD), 2 asymptomatic from sibling screens, and two from abnormalities on NBS (one presenting with unconjugated hyperbilirubinaemia and the other with cholestasis and liver failure). Two patients had liver failure (one from NICCD group and another from NBS group). None required liver transplantation. All symptomatic patients had raised citrulline and threonine-serine ratios at presentation. None of the patients was prescribed any regular concomitant medications except for MCT oil. No genotype phenotype correlation was observed. At final assessment, all patients showed normalisation of liver parameter, galactose and plasma amino acids. Abnormalities in lipid profile in 9 patients (age 5-16 years) showed borderline high total cholesterol (median 5.4 mmol/L) and LDL (median 3.0 mmol/L) which was on the higher end of the normal range. Sixty-six percent of patients liver imaging findings were normal or showed stable changes. Food preferences (assessed in ≥1-year olds) did not reflect a clear bias towards high protein/fat diet. Adherence appeared to improve with a more prescriptive approach, it waned with age (more so in dietary aspects versus the use of MCT oil). Hospital admissions were few (median 1/patient) and unrelated to CD. Overall improvements were seen in weight, height and BMI for age z-scores, showing median weight/height/BMI for age z-scores to be -0.72, -0.83, 0.08, respectively. None had neurodevelopmental concerns.</p><p><strong>Conclusion: </strong>CD remains challenging to diagnose biochemically at all ages. Current NBS strategies require further refining to increase pick up rates of CD. Cascade screening utilising genetic testing is recommended due to the presence of phenotypic heterogeneity among patients with the same genotype. However, in the absence of available genetic testing, CD should be considered in all children presenting with prolonged conjugated hyperbilirubinaemia in the presence of elevated ALP, total galactose, with/without transaminitis and typical PAA profile. With our standard treatment for CD, we observed: (i) normalisation of biochemical parameters, (ii) normalisation/stabilisation of liver imaging findings, (iii) improvements in weight/height/BMI for age scores. Adoption of a prescriptive approach appeared to encourage treatment adherence.</p><p><strong>Synopsis: </strong>This retrospective study examines 18 patients with citrin deficiency at KK Women's and Children's Hospital in Singapore, the largest cohort reported in Southeast Asia. The study assesses clinical, biochemical, imaging findings, and outcome measures. Results showed improvements in growth, biochemical normalisation, and stable liver imaging with standard treatment (dietary adjustments and MCT oil). While NBS detected some cases, there remains a need for better screening strategies. This study also demonstrated a lack of genotype-phenotype correlation, suggesting that cascade screening utilising genetic testing are crucial for early diagnosis.</p>\",\"PeriodicalId\":18937,\"journal\":{\"name\":\"Molecular genetics and metabolism\",\"volume\":\"146 1-2\",\"pages\":\"109215\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular genetics and metabolism\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ymgme.2025.109215\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/7/29 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular genetics and metabolism","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.ymgme.2025.109215","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:Citrin缺乏症(CD)是由SLC25A13基因致病变异引起的一种泛民族常染色体隐性先天性代谢错误,可导致糖酵解、糖异生、脂肪生成、尿素循环和三羧酸循环等多种代谢途径的中断。方法:2016年8月至2024年8月,在新加坡单一中心(KK妇女和儿童医院,KKH)根据标准临床实践对CD患者进行回顾性观察研究。我们介绍了东南亚报道的最大的患者队列,重点关注诊断时的临床、生化和影像学发现,以及长期结果/管理(包括药物治疗、食物偏好/依从性、住院、生长、神经发育、生化和影像学结果)。我们还探讨了新生儿筛查(NBS)作为早期发现CD的一种手段的效用。结果:18例CD患者(9例男性;2对兄弟姐妹)多数为华裔(n = 16),中位随访时间为5年5个月。首次出现和诊断时的中位年龄分别为50天和82天。14例患者表现为由CD (NICCD)引起的新生儿肝内胆汁淤积,2例来自兄弟姐妹筛查无症状,2例来自NBS异常(1例表现为非共轭高胆红素血症,另1例表现为胆汁淤积和肝功能衰竭)。2例患者发生肝功能衰竭(NICCD组1例,NBS组1例)。没有人需要肝移植。所有有症状的患者在就诊时瓜氨酸和苏氨酸-丝氨酸比值均升高。除了MCT油外,所有患者都没有开任何常规的伴随药物。未观察到基因型与表型相关。在最终评估时,所有患者的肝脏参数、半乳糖和血浆氨基酸均恢复正常。9例患者(5-16岁)血脂异常,总胆固醇(中位数5.4 mmol/L)和低密度脂蛋白(中位数3.0 mmol/L)处于正常范围的高端。66%的患者肝脏影像学检查结果正常或显示稳定的变化。食物偏好(在≥1岁的儿童中评估)没有反映出对高蛋白/脂肪饮食的明显偏见。依从性似乎随着更规范的方法而改善,随着年龄的增长而减弱(在饮食方面比使用MCT油更明显)。入院人数很少(中位1人/例),与CD无关。年龄z分数的体重、身高和BMI均有总体改善,年龄z分数的体重/身高/BMI中位数分别为-0.72、-0.83和0.08。没有人有神经发育方面的问题。结论:对所有年龄段的乳糜泻进行生化诊断仍然具有挑战性。目前的NBS策略需要进一步完善,以提高CD的拾取率。由于相同基因型患者之间存在表型异质性,建议使用基因检测进行级联筛查。然而,在缺乏可用的基因检测的情况下,所有出现ALP升高、总半乳糖升高、伴有/不伴有转氨炎和典型PAA特征的长期结合性高胆红素血症的儿童都应考虑CD。通过我们对CD的标准治疗,我们观察到:(i)生化参数正常化,(ii)肝脏影像学结果正常化/稳定,(iii)体重/身高/年龄评分BMI改善。采用规定性方法似乎鼓励治疗依从性。摘要:本回顾性研究调查了新加坡KK妇女儿童医院的18例柠檬素缺乏症患者,这是东南亚报道的最大队列。该研究评估了临床、生化、影像学表现和结果测量。结果显示,标准治疗(饮食调整和MCT油)改善了生长、生化正常化和稳定的肝脏影像学。虽然国家统计局发现了一些病例,但仍需要更好的筛查策略。该研究还表明缺乏基因型-表型相关性,表明利用基因检测的级联筛选对早期诊断至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Deep phenotyping of patients with citrin deficiency in Singapore- single centre experience.

Background: Citrin deficiency (CD) is a pan-ethnic autosomal recessive inborn error of metabolism due to-pathogenic variants in the SLC25A13 gene which results in disruptions of multiple metabolic pathways including glycolysis, gluconeogenesis, lipogenesis, the urea cycle, and tricarboxylic cycle.

Methods: A retrospective observational study of CD patients managed according to standard clinical practice at a single centre in Singapore (KK Women's and Children's Hospital, KKH) was undertaken from August 2016-August 2024. We present the largest cohort of patients reported in Southeast Asia focusing on clinical, biochemical and imaging findings at diagnosis, and long-term outcomes/management (including drug therapy, food preferences/adherence, hospital admissions, growth, neurodevelopmental, biochemical, and imaging outcomes). We also explore the utility of newborn screening (NBS) as a means for early detection of CD.

Results: Eighteen CD patients (9 males; 2 sibling pairs) majority of Chinese ethnicity (n = 16) with a median duration of follow up 5 years 5 months, participated in this study. Median age at first presentation and at diagnosis was 50 days and 82 days, respectively. Fourteen patients presented with neonatal intrahepatic cholestasis caused by CD (NICCD), 2 asymptomatic from sibling screens, and two from abnormalities on NBS (one presenting with unconjugated hyperbilirubinaemia and the other with cholestasis and liver failure). Two patients had liver failure (one from NICCD group and another from NBS group). None required liver transplantation. All symptomatic patients had raised citrulline and threonine-serine ratios at presentation. None of the patients was prescribed any regular concomitant medications except for MCT oil. No genotype phenotype correlation was observed. At final assessment, all patients showed normalisation of liver parameter, galactose and plasma amino acids. Abnormalities in lipid profile in 9 patients (age 5-16 years) showed borderline high total cholesterol (median 5.4 mmol/L) and LDL (median 3.0 mmol/L) which was on the higher end of the normal range. Sixty-six percent of patients liver imaging findings were normal or showed stable changes. Food preferences (assessed in ≥1-year olds) did not reflect a clear bias towards high protein/fat diet. Adherence appeared to improve with a more prescriptive approach, it waned with age (more so in dietary aspects versus the use of MCT oil). Hospital admissions were few (median 1/patient) and unrelated to CD. Overall improvements were seen in weight, height and BMI for age z-scores, showing median weight/height/BMI for age z-scores to be -0.72, -0.83, 0.08, respectively. None had neurodevelopmental concerns.

Conclusion: CD remains challenging to diagnose biochemically at all ages. Current NBS strategies require further refining to increase pick up rates of CD. Cascade screening utilising genetic testing is recommended due to the presence of phenotypic heterogeneity among patients with the same genotype. However, in the absence of available genetic testing, CD should be considered in all children presenting with prolonged conjugated hyperbilirubinaemia in the presence of elevated ALP, total galactose, with/without transaminitis and typical PAA profile. With our standard treatment for CD, we observed: (i) normalisation of biochemical parameters, (ii) normalisation/stabilisation of liver imaging findings, (iii) improvements in weight/height/BMI for age scores. Adoption of a prescriptive approach appeared to encourage treatment adherence.

Synopsis: This retrospective study examines 18 patients with citrin deficiency at KK Women's and Children's Hospital in Singapore, the largest cohort reported in Southeast Asia. The study assesses clinical, biochemical, imaging findings, and outcome measures. Results showed improvements in growth, biochemical normalisation, and stable liver imaging with standard treatment (dietary adjustments and MCT oil). While NBS detected some cases, there remains a need for better screening strategies. This study also demonstrated a lack of genotype-phenotype correlation, suggesting that cascade screening utilising genetic testing are crucial for early diagnosis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Molecular genetics and metabolism
Molecular genetics and metabolism 生物-生化与分子生物学
CiteScore
5.90
自引率
7.90%
发文量
621
审稿时长
34 days
期刊介绍: Molecular Genetics and Metabolism contributes to the understanding of the metabolic and molecular basis of disease. This peer reviewed journal publishes articles describing investigations that use the tools of biochemical genetics and molecular genetics for studies of normal and disease states in humans and animal models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信